What Is IJT? iShares S&P Small-Cap 600 Growth ETF

Last updated October 2026

Short answer

IJT is iShares S&P Small-Cap 600 Growth ETF, an ETF that tracks the S&P SmallCap 600 Growth Index at a 0.18% expense ratio. IJT holds the growth half of the S&P SmallCap 600, an index whose eligibility rules require a record of positive earnings before a company can join. That single requirement makes it a different animal from other small-cap growth funds. The sector mix reflects it: as of October 2026 technology at 18.5% and industrials at 18.3% are effectively tied for the lead, with healthcare at 16% and financials at 14%. Top positions include FormFactor at 1.4%, Viasat at 1.2% and Protagonist Therapeutics at 1.1%. iShares charges 0.18%, the yield is 0.78%, assets are $7.6B, and the fund dates to 2000. As of the 2026-10-16 close at $160.13, its price was up 12.2% for the year to date and 14.1% over twelve months, but down 7.8% over the past three months.

Ticker
IJT
Issuer
iShares
Tracks
the S&P SmallCap 600 Growth Index
Expense ratio
0.18%
AUM
$7.6B
YTD return
See chart
Dividend yield
0.78%
Inception
2000

IJT is issued by iShares and tracks the S&P SmallCap 600 Growth Index. It charges a 0.18% expense ratio, holds approximately $7.6B in assets under management, yields about 0.78%, and launched in 2000.

Stats as of October 2026. Live prices and current performance show inside Walnut once you connect a broker.

Growth, filtered through a profitability gate

Most small-cap growth indexes start from a universe defined only by size, which means they can select the fastest-growing companies from a pool that includes many with no earnings at all. The S&P SmallCap 600 applies an earnings requirement to the universe first. Growth characteristics are then measured within that filtered set. The order of operations is the whole story: companies are screened for profitability before they are screened for growth.

What survives that process is not the archetype of small-cap growth investing. Rather than pre-revenue biotechnology and unprofitable software, the fund fills up with engineering and construction firms, specialist manufacturers, commercial services businesses and profitable niche technology companies. In October 2026 the top ten includes ESCO Technologies, an industrial products manufacturer, Zurn Elkay Water Solutions, which makes water management products, and Armstrong World Industries, a ceiling and wall systems maker. Argan and Everus Construction Group, two construction firms in the August top ten, have since dropped below it.

The healthcare weight of 16% is where the gate shows most clearly. Protagonist Therapeutics at 1.1% and TG Therapeutics at 1.0% are now the top-ten healthcare names, replacing Krystal Biotech and Alkermes from August. Biotechnology companies only reach this index by clearing the earnings requirement, which is why the ones here have revenue rather than only a pipeline.

Reading the holdings correctly

Approximate weights as of October 2026; refresh quarterly from iShares's fund page. Each ticker links to its individual stock guide in Walnut.

RankTickerCompany% of IJT
1FORMFormFactor Inc1.4%
2VSATViasat Inc1.2%
3PTGXProtagonist Therapeutics Inc1.1%
4RHPRyman Hospitality Properties Inc1.0%
5TGTXTG Therapeutics Inc1.0%
6SNEXStoneX Group Inc0.9%
7MSGSMadison Square Garden Sports Corp Class A0.9%
8ESEESCO Technologies Inc0.8%
9ZWSZurn Elkay Water Solutions Corp0.8%
10AWIArmstrong World Industries Inc0.8%

The August 2026 list included BlackRock Cash Funds Treasury at 1.2%, which is not a company. It is a cash management vehicle used for settlement and collateral, common in iShares funds and not a portfolio position in any meaningful sense. The October list shows ten operating companies, running from FormFactor at 1.4% down to Armstrong World Industries at 0.8%.

Those weights are larger than in a full small-cap index but still modest. FormFactor makes semiconductor test equipment, Viasat operates satellite communications, Ryman Hospitality Properties owns large convention hotels, Madison Square Garden Sports owns the Knicks and Rangers, and StoneX is a financial services and brokerage firm. It is a heterogeneous list, which is what a growth screen applied to a profitable small-cap universe produces: no dominant theme, just companies whose earnings and sales are expanding.

There is a size point buried in the list as well. The S&P SmallCap 600 sits below the mid-cap range, and its growth half is drawn from companies that are profitable but still small. Set against a mid-cap growth fund, these businesses are earlier in their commercial life and more exposed to a single product line or a small number of customers. Set against a size-only small-cap index, they are further along, because the earnings requirement removes companies still funding themselves through capital raises.

Fee, income and the boundaries

At 0.18% the fund costs more than a broad small-cap index fund but sits at the cheaper end of style-specific products. The premium buys the index construction, not management judgment. The 0.78% yield is the lowest sort of figure you will see outside a pure growth fund, since growth companies of this size reinvest rather than distribute.

IJT is the wrong tool for someone wanting exposure to speculative small-cap growth, because the earnings requirement excludes exactly that segment. It is also the wrong tool for anyone who assumes a growth label implies a technology-dominated portfolio, given industrials carry as much weight as technology here. And it duplicates a large part of any broad small-cap holding, since the growth half of an index is drawn from the same companies a total small-cap fund already owns.

Turnover is the other cost worth noting. Companies move between the growth and value halves of the index as their characteristics change, and they leave the parent index entirely when they grow too large or stop meeting the earnings requirement. That produces more trading than a broad market fund, which shows up in the fund's internal transaction costs rather than in the stated expense ratio. It is a general feature of style indexes rather than a flaw specific to this one.

Recent trading shows the volatility that comes with the size bracket. The fund's price rose 12.2% in 2026 through 2026-10-16 and 14.1% over twelve months, but fell 7.8% over the last three months, and Yahoo lists its 3-year beta at 1.08. Assets declined from $8.2B in August to $7.6B in October, a drop that reflects both the price decline and possible outflows; the data does not separate the two.

How do I invest in IJT?

There are three common ways to get IJT exposure. Buy shares (or fractional shares) of IJT directly at any major broker that lists it. Hold it as a core position and layer more concentrated ideas on top. Or build it into a thematic portfolio in Walnut, so IJT sits alongside other holdings that express the same thesis, with target weights you can rebalance toward. IJT trades like a stock during market hours, so you buy it the same way you would any listed share.

New to buying funds? See how to buy an ETF, step by step.

Is IJT a good buy?

Whether IJT is a good buy depends less on any single call and more on your time horizon and what you already hold: it tracks the S&P SmallCap 600 Growth Index, so the real question is whether you want that exposure in your mix and at what weight. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is IJT a buy?

The bottom line on IJT

IJT gives you the S&P SmallCap 600 Growth Index exposure in one ticker at a 0.18% expense ratio. Most investors use it as a core holding and layer more concentrated thematic portfolios on top.

More on IJT

Whether IJT is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, concentration, and what would have to be true for it to outperform from here in is IJT a buy?

IJT yields 0.78% as of October 2026, paid by passing through the dividends of its underlying holdings. For the payout schedule, history, and how the distributions are taxed, see IJT dividend: yield and schedule.

For what analysts expect from the companies IJT holds, its yield as a guide to income, and why no one publishes a price target for the fund itself, see the IJT forecast.

New to funds like IJT? Start with what an ETF is, then how to buy an ETF, or browse the full guide to ETF investing.

Wondering how IJT fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Investing in IJT with AI

Connect the broker you already use and ask Walnut's AI how IJT fits what you actually hold: what it overlaps with, what it leaves you exposed to, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

What makes the S&P SmallCap 600 different from the Russell 2000?

+

The S&P index requires a record of positive earnings before a company can be admitted; the Russell 2000 selects on size alone. That single rule removes a large tail of unprofitable companies. The two universes overlap heavily, but the S&P version skews toward established small businesses while the Russell version includes more speculative names.

Why is industrials as large as technology in a growth fund?

+

Because growth is measured within a universe already screened for profitability. Once companies without earnings are excluded, the fastest-growing survivors include a great many engineering, construction, capital equipment and commercial services firms. Industrials reach 18% here, level with technology, which would be unusual in a growth index built on size alone. In August 2026 industrials were narrowly ahead; by October technology had edged back in front by a fraction of a point.

What is BlackRock Cash Funds Treasury doing in the holdings?

+

It is a cash management vehicle used for settlement, collateral and securities lending, not an investment position. It appeared at 1.2% in the August 2026 holdings list and does not appear in the October top ten. Many iShares funds show one at times. Treat the real portfolio as beginning with FormFactor at 1.4% and running through the operating companies below it, and read published holdings tables with that convention in mind.

How does the fund define growth?

+

Standard index methodology scores companies on measures such as sales growth, earnings change relative to price and price momentum, then assigns them to the growth or value half of the parent index. Companies with mixed characteristics can appear in both halves at partial weight, which is why a growth and value pair does not always split cleanly down the middle.

Why is the yield only 0.78%?

+

Growth-classified small companies retain earnings to fund expansion rather than distributing them, and the growth screen actively selects for that behaviour. A small-cap value fund drawn from the same parent index would yield considerably more. Anyone holding IJT for income has chosen the wrong half of the S&P SmallCap 600.

Does IJT overlap with a total small-cap fund?

+

Heavily. The growth half of the S&P SmallCap 600 is drawn from companies that a broad small-cap fund already owns, so holding both concentrates rather than diversifies. The reason to own IJT separately is to deliberately overweight profitable small-cap growth relative to the rest of the small-cap market.

How concentrated are the positions?

+

Moderately. FormFactor at 1.4% is the largest real holding, and the ten biggest sit between 0.8% and 1.4%. That is more concentrated than a full small-cap index, where nothing reaches half a per cent, but still diffuse enough that no single company determines results. Sector weights remain the more meaningful description.

Who should look elsewhere?

+

Investors seeking speculative or pre-revenue small caps, which the earnings requirement excludes by design. Investors expecting a technology-led portfolio, given industrials at 18% match technology in the sector table. And investors seeking income, since the 0.78% yield is a consequence of the growth screen rather than something the fund attempts to manage.

What is IJT's expense ratio?

+

IJT has an expense ratio of 0.18% per year as of October 2026, charged by iShares and deducted from the fund's value rather than billed to you separately. On a $10,000 position that is roughly $18 a year. Fees compound over time, so on a long-term holding the expense ratio is one of the few return drivers you control. It is worth comparing against other funds that track the S&P SmallCap 600 Growth Index before you choose.

How do I compare IJT to similar ETFs?

+

Put a few fields side by side: the expense ratio (fees compound over decades), the index or strategy it tracks, the top holdings and how much they overlap with what you already own, the dividend yield, and the AUM, liquidity, and bid-ask spread that affect trading costs. For index funds, tracking error (how closely it follows its index) and tax efficiency matter too. IJT's figures are above; the full method is in Walnut's guide on how to compare ETFs.

Related ETFs

Walnut is informational, not investment advice. Holdings weights and fund statistics on this page are approximations stamped to October 2026; verify current figures against iShares's fund page or your broker before investing.